medwireNews: Tirzepatide at a maximum tolerated dose (MTD) of 10 to 15 mg can enhance the weight loss achieved following an intensive lifestyle intervention, show the results of the SURMOUNT-3 trial.
27-10-2023 | Obesity | News
27-10-2023 | Obesity | News
medwireNews: Tirzepatide at a maximum tolerated dose (MTD) of 10 to 15 mg can enhance the weight loss achieved following an intensive lifestyle intervention, show the results of the SURMOUNT-3 trial.